Sipai Health Technology Co., Ltd. (HKG:0314)

Hong Kong · Delayed Price · Currency is HKD

1.320

-0.030 (-2.22%)

Jul 31, 2026, 4:08 PM HKT

Sipai Health Technology Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,071	2,071	4,565	4,712	4,119	3,474
Revenue Growth	-39.55%	-54.64%	-3.11%	14.39%	18.58%	28.68%
Gross Profit	310.2	310.2	385.53	412.45	333.97	281.06
Operating Income	-115.58	-115.58	-274.35	-283.57	-642.01	-746.69
Net Income	-124.27	-124.27	-323.74	-255.77	-1,371	-3,740
Earnings Per Share	-0.21	-0.21	-0.51	-0.40	-12.19	-37.61
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Physician Research Assistance Business	462.27	462.27	397.61	361.78	319.45	244.86
Specialty Pharmacy Business	1,467	1,467	3,975	4,188	3,662	3,136
Health Insurance Services Business	141.58	141.58	192.96	162.25	138.22	92.59
Total	2,071	2,071	4,565	4,712	4,119	3,474

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	618	618	919.77	1,130	1,531	1,608
Total Debt	22.58	22.58	45.49	67.56	67.76	7,522
Net Cash (Debt)	595.42	595.42	874.28	1,062	1,463	-5,914
Net Cash Growth	3.89%	-31.90%	-17.68%	-27.40%	-	-
Net Cash Per Share	0.99	0.99	1.37	1.65	13.01	-59.46

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-	-	-59.45	-133.5	-182.07	-621.92
Capital Expenditures	-	-	-8.46	-5.36	-3.96	-16.58
Free Cash Flow	-	-	-67.91	-138.86	-186.02	-638.5
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	14.98%	14.98%	8.44%	8.75%	8.11%	8.09%
Operating Margin	-5.58%	-5.58%	-6.01%	-6.02%	-15.58%	-21.49%
Pretax Margin	-6.19%	-6.19%	-7.90%	-5.21%	-33.22%	-107.88%
Profit Margin	-6.00%	-6.00%	-7.09%	-5.43%	-33.27%	-107.67%
FCF Margin	-	-	-1.49%	-2.95%	-4.52%	-18.38%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	0.42	0.81	0.86	1.01	3.06	-